Company
Mesa Laboratories
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
3
510(k), De Novo and PMA
Device trials
0
As lead sponsor, any status
Adverse event reports
0
Received Nov 1, 2025 to Nov 20, 2026
Recall records
7
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
Public company. Figures from its SEC financial statements.
Listed
MLAB
Nasdaq · MESA LABORATORIES INC /CO/
Public float
$358M
Value of shares held by non-insiders on Sep 30, 2025
Revenue
$249M
Fiscal year ending Mar 31, 2026
Net income
$6.7M
Fiscal year ending Mar 31, 2026
R&D spending
$20.3M
Fiscal year ending Mar 31, 2026
Cash
$22.3M
As of Sep 30, 2026
Long-term debt
$64.7M
As of Sep 30, 2026
Shares outstanding
5.6M
As of Nov 2, 2026
Capital raised as a public company
Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.
| Year | IPO | Stock sold | Long-term debt | Convertible debt |
|---|---|---|---|---|
| 2021 | – | $146M | – | – |
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
Latest FDA decisions
- SmartHDM-510 System510(k)
K201765 · Decided Sep 2, 2020 · 65 days after receipt
Device type: Meter, Conductivity, Non-Remote (FIZ) · GI, Urology & Nephrology
- TDS Standard Solution510(k)
K191496 · Decided Aug 5, 2019 · 61 days after receipt
Device type: Solution-Test Standard-Conductivity, Dialysis (FKH) · GI, Urology & Nephrology
K150657 · Decided Sep 21, 2015 · 192 days after receipt
Device type: Meter, Conductivity, Non-Remote (FIZ) · GI, Urology & Nephrology
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
No device trials list this company as lead sponsor.
Reports received
0
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
No reports to chart for this view.
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
No device types to rank.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
No brand names to rank.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1273-2018 · Started Feb 12, 2018
Reason given: The concentration of bromocresol purple in the recalled lots does not conform to specification.
Cause as FDA categorized it: Other · Device type: Indicator, Biological Sterilization Process (FRC)
Z-1274-2018 · Started Feb 12, 2018
Reason given: The concentration of bromocresol purple in the recalled lots does not conform to specification.
Cause as FDA categorized it: Other · Device type: Indicator, Biological Sterilization Process (FRC)
Z-2159-2017 · Started May 12, 2017 · Posted by FDA May 16, 2017
Reason given: Mesa Laboratories is recalling Conductivity/TDS Calibrator Solution due to failure to meet product specifications.
Cause as FDA categorized it: Process control · Device type: Solution-Test Standard-Conductivity, Dialysis (FKH)
4 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.